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A B S T R A C T
Diagnosis of Yersinia infections accompanied by
reactive arthritis could be complicated by cross-
reaction with other arthritogenic bacteria. The
possible cross-reaction between Yersinia antigens
and anti-Borrelia antibodies in blood sera of
patients with Lyme disease was studied. The
occurrence of specific IgA, IgG and IgM antibodies
was analyzed in serum samples from 30 patients
with Yersinia-triggered reactive arthritis, 30
patients with Lyme disease and five samples
from healthy blood donors. For anti-Borrelia IgG
antibodies, cross-reaction was detected with
YopH, YopB, V-ag, YopD, YopN, YopP and YopE,
and for IgA with YopD. For IgM, no cross-
reaction was detected. Owing to cross-reactivity
with Borrelia, the diagnosis of Yersinia-triggered
reactive arthritis should be based on a combina-
tion of serological and clinical findings.
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Reactive arthritis (ReA) is an aseptic joint inflam-
mation following infection with sexually trans-
mitted pathogens such as Chlamydia, or enteric
infections with Shigella, Salmonella, Campylobacter,
Yersinia, etc. [1]. Generally, 1–3% of the infected
patients develop ReA [2]. Yersinia-triggered ReA
(Ye-ReA) manifests 1–4 weeks after the onset of
infection and can persist for 1–4 months. In many
patients with Yersinia enterocolitica-triggered reac-
tive arthritis, the sacroiliac joints and spinal
column are affected and the injury progresses
during the chronic course of the disease [3].
In Bulgaria, diagnosis of Ye-ReA is based on
clinical symptoms and supported by serological
tests, i.e. the Widal agglutination reaction with
whole bacterial cells as antigen, and ELISA with
lipopolysaccharide from Yersinia as antigen. As
whole cells and purified lipopolysaccharide are
used as antigens, cross-reactivity may lead to non-
specific and false-positive reactions [4]. During
infections with Y. enterocolitica and Y. pseudotu-
berculosis, a strong immune response against
Yersinia outer membrane proteins (Yops) occurs.
Antibody levels rise during the first week of
illness, reaching a peak during the second week
after the infection, and then 3–6 months after
infection, the antibody titre returns to normal
levels. Antibodies against Yops usually persist at
high levels for a long period in sera from patients
with Yersinia infection, with and without arthritis
[5]. Patients with Ye-ReA have high serum con-
centrations of Yersinia-specific IgA class antibod-
ies [6]. Many authors have reported the detection
of antibodies against Yops using immunoblot as a
sensitive and specific serological method for
diagnosis of Yersinia-associated arthritis [7,8]. At
the same time, in serum samples from patients
with ReA, wide cross-reactivity between ‘arthro-
genic enteric bacteria’ and Borrelia burgdorferi was
established [9]. In the present study, the specific-
ity of western blots using Yops as antigens for the
detection of Yersinia antibodies was investigated.
Yops and antibodies in blood sera of patients with
Lyme disease (LD) were analyzed for the pres-
ence of cross-reactivity.
Thirty serum samples from patients with sus-
picion of Ye-ReA were obtained from the Clinic of
Rheumatology, Medical University, Sofia, Bul-
garia. Ye-ReA was defined as the development of
mono- or oligo-arthritis, the presence of HLA-B27
and the absence of rheumatoid factor. One patient
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was positive for Yersinia after a stool test. No
patient had clinical signs suggesting LD. Thirty
serum samples from patients with suspicion of
LD were obtained from the National Reference
Lyme Laboratory at the National Centre of Infec-
tious and Parasitic Disease, Sofia, Bulgaria
(Table 1). Five serum samples from healthy indi-
viduals were used as negative controls, and were
negative for the presence of anti-Yersinia and anti-
Borrelia antibodies. In total, 65 blood serum
samples, diluted 1 : 50, were analyzed using an
immunoblot assay with specific antigens, includ-
ing Yops, for the presence of anti-Yersinia IgG,
IgA and IgM antibodies. Yersinia enterocolitica
strain WA-314, serotype O:8, harbouring the
virulence plasmid pYV was used as a protein
donor. When bacteria are cultivated at 37C under
calcium restriction (<0.2 mM Ca2+), large
amounts of Yops are secreted into the medium.
Proteins were separated by two-dimensional SDS
electrophoresis. SDS-PAGE and immunoblotting
were carried out as described by Heesemann et al.
[10].
IgG antibodies in all 30 blood sera from the
patients with Ye-ReA against YopH, YopB, V-ag,
YopD, YopN, YopP and YopE were detected
(Fig. 1). IgA antibodies were formed against
YopB, YopD and YopN. IgM antibodies were
detected against YopD. The presence of antibod-
ies of the IgM class, especially those against
YopD, were described by Strobel et al. [8] as
evidence of acute infection. With the natural
presence of Yersinia in pigs (Najdenski H, Golko-
cheva E, Neykov P, Vesselinova A. Serological
screening of Yersinia infection by the classical
agglutination test and improved ELISA. Proceed-
ings of the 16th International Pig Veterinary
Society Congress, Melbourne, Australia, 17–20
September 2000:241) and in wild animals in
Bulgaria [11], a large number of clinical cases of
Ye-ReA were observed.
A B. burgdorferi ELISA (Mikrogen, Munich,
Germany) revealed only one positive serum
sample out of the 30 samples from patients with
Ye-ReA. Specific anti-Borrelia IgM and IgG anti-
bodies were detected.
Blood samples from 30 patients with clinical
manifestations related to LD and IgG or IgM
antibodies against B. burgdorferi were tested in the
National Reference Lyme Laboratory in Sofia. The
test was carried out in a manner similar to the test
for the presence of IgG, IgA and IgM antibodies
against Yersinia in blood samples from patients
with Ye-ReA. IgG antibodies were detected in 27
(90%) of the 30 Borrelia-positive sera against
YopH (7%), YopB (18%), V-ag (11%), YopD
(100%), YopN (18%), YopP (44%) and YopE
(15%). Two sera (10%) had IgA antibodies with
cross-reactivity against YopD. IgM antibodies
against Yersinia were not detected. A large
amount of cross-reactivity between B. burgdorferi
and Yersinia, as revealed by western blot and
Table 1. Characteristics of patients with Yersinia-triggered reactive arthritis (Ye-ReA), patients with Lyme disease (LD)
and healthy blood donors (H)
Ye-ReA LD H
Total number 30 30 5
Age (years), mean ± SD 25.3 ± 7.3 50.7 ± 18.4 32.0 ± 4.12
Clinical characteristics Mono-arthritis ⁄ oligo-arthritis,
diarrhoea, conjunctivitis,
spondylitis, HLA-B27(+), RF())
Erythema migrans, mono-arthritis ⁄
oligo-arthritis, myelopoliradiculoneuritis
No history of Ye-ReA or LD
Fig. 1. Immunoblot analysis of sera for anti-Yersinia outer
membrane protein (Yop) IgA, IgG and IgM antibodies.
Lanes PM and Yops: SDS-PAGE of molecular mass mark-
ers (kDa) and Yops, respectively (Coomassie stain).
Lanes 1–5: anti-Yersinia IgG antibodies in patients with
Lyme disease (LD). Lanes 6 and 7: anti-Yersinia IgA
antibodies in patients with LD. Lane 8: anti-Yersinia IgA
antibodies in a patient with Yersinia-triggered reactive
arthritis (Ye-ReA). Lane 9: anti-Yersinia IgG antibodies in a
patient with Ye-ReA. Lane 10: anti-Yersinia IgM antibodies
in a patient with Ye-ReA.
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ELISA, has been reported by Bruckbauer et al.
[12] and Rawlins et al. [13]. The most highly
cross-reactive proteins of Borrelia were p66 (a
common bacterial antigen), p41 (flagelin), p32
(OspA) and a protein of c. 20 kDa. As for anti-
Yersinia IgG, cross-reactivity was observed
against most of the excreted Yops. The highest
percentage of cross-reaction was against YopD,
which is in accordance with the results of
Rawlins et al. [13]. The cross-reactivity can be
explained by the homology between the human
thyroid-stimulating hormone receptor, four Yops
and five B. burgdorferi proteins [14]. The presence
of an IgA response indicates chronic stimulation
by the plasmid-encoded Yersinia antigens.
According to some authors, the intestinal mucosa
or areas close to it are the sites where bacterial
structures of Yersinia have been demonstrated
years after the original infection [15], which is in
agreement with the secretion of IgA class anti-
bodies observed in this study. The positive
reaction of two sera could be the result of
Yersinia infections in the past.
On the basis of the current study, detection of
IgG, IgA and IgM class antibodies with an
immunoblot assay using Yops as specific antigens
could be considered as a tool for the diagnosis of
YeRea. Owing to numerous instances of cross-
reactivity between Yersinia and other bacterial
species [16] and the homology of Yops and
thyroid autoantigens [14], the diagnosis should
be based on a combination of complete serological
findings and the clinical picture.
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